0
Anxiety and Depression in COPD: Current Understanding, Unanswered Questions, and Research Needs |

Anxiety and Depression in COPD: Current Understanding, Unanswered Questions, and Research Needs

Janet Maurer, MD, MBA, FCCP; Venkata Rebbapragada, MD; Soo Borson, MD; Roger Goldstein, MBChB, FCCP; Mark E. Kunik, MD, MPH; Abebaw M. Yohannes, PhD; Nicola A. Hanania, MBBS, MD, FCCP; for the ACCP Workshop Panel on Anxiety and Depression in COPD
Author and Funding Information

*From Health Dialog, Inc. (Dr. Maurer), Phoenix, AZ; Section of Pulmonary and Critical Care Medicine (Drs. Rebbapragada and Hanania), Baylor College of Medicine, Houston, TX; Psychiatry and Behavioral Sciences (Dr. Borson), University of Washington School of Medicine, Seattle, WA; Medicine and Physical Therapy (Dr. Goldstein), University of Toronto, Toronto, ON, Canada; Michael E. DeBakey Veterans Affairs Medical Center (Dr. Kunik), Houston, TX; and Manchester Metropolitan University (Mr. Yohannes), Manchester, UK.

Correspondence to: Nicola A. Hanania, MBBS, MD, FCCP, Associate Professor of Medicine, Section of Pulmonary and Critical Care Medicine, 1504 Taub Loop, Houston, TX 77030; e-mail: Hanania@bcm.edu


A list of speakers is given in the Appendix.

This workshop was supported by grant R13-MH073228-01A1 from the National Institute of Mental Health and the Alpha-1 Foundation.

The authors disclose that no financial or other potential conflicts of interest exist.

Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (www.chestjournal.org/misc/reprints.shtml).


Chest. 2008;134(4_suppl):43S-56S. doi:10.1378/chest.08-0342
Text Size: A A A
Published online

Background:  Approximately 60 million people in the United States live with one of four chronic conditions: heart disease, diabetes, chronic respiratory disease, and major depression. Anxiety and depression are very common comorbidities in COPD and have significant impact on patients, their families, society, and the course of the disease.

Methods:  We report the proceedings of a multidisciplinary workshop on anxiety and depression in COPD that aimed to shed light on the current understanding of these comorbidities, and outline unanswered questions and areas of future research needs.

Results:  Estimates of prevalence of anxiety and depression in COPD vary widely but are generally higher than those reported in some other advanced chronic diseases. Untreated and undetected anxiety and depressive symptoms may increase physical disability, morbidity, and health-care utilization. Several patient, physician, and system barriers contribute to the underdiagnosis of these disorders in patients with COPD. While few published studies demonstrate that these disorders associated with COPD respond well to appropriate pharmacologic and nonpharmacologic therapy, only a small proportion of COPD patients with these disorders receive effective treatment.

Conclusion:  Future research is needed to address the impact, early detection, and management of anxiety and depression in COPD.


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543